Join
Live feed
·
INSIDERFilingvia Quantisnow
Enliven Therapeutics Inc. logo

Director Kunkel Lori Anne sold $504,903 worth of shares (10,000 units at $50.49) as part of a pre-agreed trading plan, decreasing direct ownership by 19% to 41,884 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ELVN· Enliven Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ELVN (Enliven Therapeutics Inc.) and more on Quantisnow.

Director Kunkel Lori Anne sold $504,903 worth of shares (10,000 units at $50.49) as part of a pre-agreed trading plan, decreasing direct ownership by 19% to 41,884 units (SEC Form 4) | Quantisnow